Compare YPF & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YPF | WST |
|---|---|---|
| Founded | 1977 | 1923 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9B | 18.5B |
| IPO Year | 1995 | 2004 |
| Metric | YPF | WST |
|---|---|---|
| Price | $45.23 | $297.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $45.67 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 2.1M | 869.2K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.30% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | N/A | ★ 1.92 |
| Revenue | N/A | ★ $2,886,900,000.00 |
| Revenue This Year | $14.39 | $6.76 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | ★ N/A | $153.84 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $22.82 | $203.74 |
| 52 Week High | $48.96 | $322.34 |
| Indicator | YPF | WST |
|---|---|---|
| Relative Strength Index (RSI) | 64.15 | 66.82 |
| Support Level | $33.02 | $234.43 |
| Resistance Level | $48.96 | $321.34 |
| Average True Range (ATR) | 1.26 | 8.50 |
| MACD | 0.11 | 1.96 |
| Stochastic Oscillator | 99.66 | 64.60 |
YPF SA is an Argentina-based integrated oil and gas company. The company operates through four business segments: Upstream, Midstream and Downstream, LNG and Integrated Gas, and New Energies. The Upstream segment focuses on the exploration and production of crude oil and natural gas. The Midstream and Downstream segment includes refining, transportation, and commercialization of crude oil, refined, and petrochemical products. The LNG and Integrated Gas segment is involved in natural gas transportation, processing, storage, and commercialization. The New Energies segment focuses on energy transition initiatives, including natural gas distribution, power generation, renewable energy, and related technology development. It generates majority of revenue from Midstream and Downstream segment.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.